Marta Cejudo‐Guillén

Marta Cejudo‐Guillén

Auto-generated profile, based on publicly available information

Marta Cejudo‐Guillén

CABIMER, Andalusian Center for Molecular Biology and Regenerative Medicine, Av. Americo Vespucio s/n, 41092, Seville, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2017
Verified
Book Chapter
Closed access
PDF file
AJAlba Jimenez-Pacheco
Alba Jimenez-Pacheco
JFJaime M. Franco
Jaime M. Franco
SLSoledad López-Enríquez
Soledad López-Enríquez
JGJuan Miguel Gomez-Zumaquero
Juan Miguel Gomez-Zumaquero
MLMaria Magdalena Leal-Lasarte
Maria Magdalena Leal-Lasarte
David PozoDavid Pozo
David Pozo

1 January 2016 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
DCDiana Elia Caballero-Hernández
Diana Elia Caballero-Hernández
MTMiguel G. Toscano
Miguel G. Toscano
MCMarta Cejudo-Guillen
Marta Cejudo-Guillen
María Luisa García-MartínMaría Luisa García-Martín
María Luisa García-Martín
SLSoledad López-Enríquez
Soledad López-Enríquez
David PozoDavid Pozo
David Pozo

1 December 2012 in Acta Biomaterialia
Verified
Journal Article
Closed access
MCM. Cejudo-Guillén
M. Cejudo-Guillén
MRM.L. Ramiro-Gutiérrez
M.L. Ramiro-Gutiérrez
ALA. Labrador-Garrido
A. Labrador-Garrido
ADAránzazu Díaz-Cuenca
Aránzazu Díaz-Cuenca
David PozoDavid Pozo
David Pozo

6 October 2015 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
ALAdahir Labrador‐Garrido
Adahir Labrador‐Garrido
MCMarta Cejudo‐Guillén
Marta Cejudo‐Guillén
SDSoumya Daturpalli
Soumya Daturpalli
MLMaría M. Leal
María M. Leal
RKRebecca Klippstein
Rebecca Klippstein
CRCintia Roodveldt
Cintia Roodveldt
We have investigated the potential role of molecular chaperones as modulators of the immune response by using α‐synuclein (αSyn) as an aggregation‐prone model protein. We first performed an in vitro immunoscreening with 21 preselected candidate chaperones and selected 2 from this set as displaying immunological activity with differential profiles, Grp94/Gp96 and FKBP4/52. We then immunized mice with both chaperone/α‐synuclein combinations using monomeric or oligomeric α‐synuclein (MαSyn or OαSyn, respectively), and we characterized the immune response generated in each case. We found that Grp94 promoted αSyn‐specific T‐helper (T h )1/T h 17 and IgG1 antibody responses (up to a 3‐fold increase) with MαSyn and OαSyn, respectively, coupled to a T h 2‐type general phenotype (generating 2.5‐fold higher IgG1/IgG2 levels). In addition, we observed that FKBP4 favored a T h 1‐skewed phenotype with MαSyn but strongly supported a T h 2‐type phenotype with OαSyn (with a 3‐fold higher IL‐10/IFN‐γ serum levels). Importantly, results from adoptive transfer of splenocytes from immunized animals in a Parkinson's disease mouse model indicates that these effects are robust, stable in time, and physiologically relevant. Taken together, Grp94 and FKBP4 are able to generate differential immune responses to α‐synuclein‐based immunizations, depending both on the nature of the chaperone and on the aggregation state of α‐synuclein. Our work reveals that several chaperones are potential modulators of the immune response and suggests that different chaperones could be exploited to redirect the amyloid‐elicited immunity both for basic studies of the immunological processes associated with neurodegeneration and for immunotherapy of pathologies associated with protein misfolding and aggregation.—Labrador‐Garrido, A., Cejudo‐Guillen, M., Daturpalli, S., Leal, M. M., Klippstein, R., De Genst, E. J., Villadiego, J., Toledo‐Aral, J. J., Dobson, C. M., Jackson, S. E., Pozo, D., Roodveldt, C. Chaperome screening leads to identification of Grp94/Gp96 and FKBP4/52 as modulators of the α‐synuclein‐elicited immune response. FASEB J. 30, 564‐577 (2016). www.fasebj.org

1 December 2014 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
PDF file
ALAdahir Labrador‐Garrido
Adahir Labrador‐Garrido
MCMarta Cejudo‐Guillén
Marta Cejudo‐Guillén
RKRebecca Klippstein
Rebecca Klippstein
EGErwin J. De Genst
Erwin J. De Genst
LGLaura Tomás Gallardo
Laura Tomás Gallardo
CRCintia Roodveldt
Cintia Roodveldt
α‐Synuclein (αSyn) is a 140‐residue amyloid‐forming protein whose aggregation is linked to Parkinson's disease (PD). It has also been found to play a critical role in the immune imbalance that accompanies disease progression, a characteristic that has prompted the search for an effective αSyn‐based immunotherapy. In this study, we have simultaneously exploited two important features of certain heat‐shock proteins (HSPs): their classical “chaperone” activities and their recently discovered and diverse “immunoactive” properties. In particular, we have explored the immune response elicited by immunization of C57BL/6 mice with an αSyn/Hsp70 protein combination in the absence of added adjuvant. Our results show differential effects for mice immunized with the αSyn/Hsp70 complex, including a restrained αSyn‐specific (IgM and IgG) humoral response as well as minimized alterations in the Treg (CD4+CD25+Foxp3+) and Teff (CD4+Foxp3−) cell populations, as opposed to significant changes in mice immunized with αSyn and Hsp70 alone. Furthermore, in vitro‐stimulated splenocytes from immunized mice showed the lowest relative response against αSyn challenge for the “αSyn/Hsp70” experimental group as measured by IFN‐γ and IL‐17 secretion, and higher IL‐10 levels when stimulated with LPS. Finally, serum levels of Th1‐cytokine IFN‐γ and immunomodulatory IL‐10 indicated a unique shift toward an immunomodulatory/immunoprotective phenotype in mice immunized with the αSyn/Hsp70 complex. Overall, we propose the use of functional “HSP‐chaperoned amyloid/aggregating proteins” generated with appropriate HSP‐substrate protein combinations, such as the αSyn/Hsp70 complex, as a novel strategy for immune‐based intervention against synucleinopathies and other amyloid or “misfolding” neurodegenerative disorders.